The head of Myanmar’s military government, Senior Gen. Min Aung Hlaing, told a forum for relief donations in Naypyitaw that 2 ...

ByteBrain is an IT Consulting Agency based in Sheridan, dedicated to helping businesses leverage Generative AI, data, and ...

Medera announced that updated results from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial investigating SRD-002, a one-time gene therapy ...

Healthcare and medical manufacturing in Australia is gaining momentum with ASX companies at the forefront of growth.

By Ricardo Martins in Utrecht Brazilian President Lula da Silva concluded a busy diplomatic tour across Asia last week, ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

D Molecular Therapeutics, Inc.’s FDMT share price has dipped by 10.90%, which has investors questioning if this is right time to buy.

Rising costs threaten to blow out the $6 billion budget companies are permitted to charge customers for upgrades to their ...

Proof of principle data from Phase I part of the Phase I/II trial of TG4050 in the adjuvant setting of head and neck cancer. All TG4050-treated patients remained disease-free after median follow-up of ...

SOMERVILLE, Mass., March 28, 2025--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ...

Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...